IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Home (in Vivo)

IV_new_banner3new_highwire_logo

PRINT ISSN: 0258-851X
ONLINE ISSN: 1791-7549

In Vivo is an international journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management. IN VIVO was established in 1987 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, submission of manuscripts, contents of previous volumes and a current list of accepted manuscripts.

The IN VIVO Special Issue on SARS-Cov-2 and Covid-19 Disease
is available OPEN ACCESS at Highwire and here.

All articles on SARS-Cov-2 and Covid-19 Disease can now be accessed here,
and are also available through Highwire.

From January 2017 In Vivo is published online – only with open access through Stanford University HighWire Press. Free online access of Full-text or PDF (from January 2009), or PDF-only (from January 2004 to December 2008) articles will be available through Stanford University HighWire Press. Articles published before 2004 (Volumes 1/1987 – 17/2003) are available through the Editorial Office.

Impact factor (2019): 1.541
Total articles: 234
Total cites: 2,875

Now the entire contents of In Vivo published from 2013 till today
can be accessed for free from Android, iPhone, iPad and compatible Chromebook devices.

Contents of Current Issue

Archive of All Online Issues (January 2004 – Present)

  • 1987 – 2019
  • 33 volumes
  • over 27,000 pages
  • over 4,100 original articles and reviews
  • over 27,800 authors
  • conference abstracts
  • special issues
  • author and subject detailed indexes
  • included in Pubmed and most abstracting services
  • online open access with Stanford University HighWire Press
  • safe processing of all submitted manuscripts
  • rapid publication within 1-2 months of acceptance
  • no fees for language and style corrections
  • immediate contact with the Editorial Office

ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
e-mail: journals@iiar-anticancer.org

Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389
e-mail:journals@iiar-anticancer.org

IMPORTANT NOTE: You may submit your article only through our online submission system

Submit your manuscript